0000915913-22-000139.txt : 20220901
0000915913-22-000139.hdr.sgml : 20220901
20220901161253
ACCESSION NUMBER: 0000915913-22-000139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220831
FILED AS OF DATE: 20220901
DATE AS OF CHANGE: 20220901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crawford Raphael Goszcz
CENTRAL INDEX KEY: 0001776484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12658
FILM NUMBER: 221221090
MAIL ADDRESS:
STREET 1: 4311 GREENBRIAR HILLS PLANTATION RD
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBEMARLE CORP
CENTRAL INDEX KEY: 0000915913
STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
IRS NUMBER: 541692118
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4250 CONGRESS STREET
STREET 2: SUITE 900
CITY: CHARLOTTE
STATE: NC
ZIP: 28209
BUSINESS PHONE: 980-299-5700
MAIL ADDRESS:
STREET 1: 4250 CONGRESS STREET
STREET 2: SUITE 900
CITY: CHARLOTTE
STATE: NC
ZIP: 28209
FORMER COMPANY:
FORMER CONFORMED NAME: ECHEM INC
DATE OF NAME CHANGE: 19931208
4
1
wf-form4_166206315260917.xml
FORM 4
X0306
4
2022-08-31
0
0000915913
ALBEMARLE CORP
ALB
0001776484
Crawford Raphael Goszcz
ALBEMARLE CORPORATION
4250 CONGRESS STREET, SUITE 900
CHARLOTTE
NC
28209
0
1
0
0
President, Catalysts
Common Stock
2022-08-31
4
M
0
7218
91
A
25914
D
Common Stock
2022-08-31
4
S
0
7218
268.28
D
18696
D
Common Stock
2022-08-31
4
S
0
320
271.24
D
18376
D
Common Stock
2022-08-31
4
S
0
2839
21.59
D
15537
D
Common Stock
2022-08-31
4
S
0
7591
270.20
D
7946
D
Stock Option
91.0
2022-08-31
4
M
0
7218
0
D
2022-02-26
2029-02-25
Common Stock
7218.0
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.05 to $269.65, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On February 26, 2019, the reporting person was granted a 10-year option exercisable for 7,218 shares of Common Stock. The option cliff-vested on 2/26/2022.
/s/ Stefanie M. Holland, Attorney-in-Fact
2022-09-01